Bilateral salpingectomy as an option of permanent contraception at time of caesarean section: A survey of practice
Australian and New Zealand Journal of Obstetrics and Gynaecology · 2024
DOI: 10.1111/ajo.13748 ↗Kurz gefasst
Fachartikel in der Zeitschrift Australian and New Zealand Journal of Obstetrics and Gynaecology, 2024. Verfasst von Nargis Noori und 7 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics and Gynaecology Department, Westmead Hospital, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Ovarian Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Background
Opportunistic bilateral salpingectomy during benign gynaecologic surgery is advocated as a risk‐reducing strategy due to the inverse association of epithelial ovarian cancers observed in epidemiological studies in a low‐risk setting. Currently, no formal guidance exists for permanent surgical contraception at time of caesarean section in Australia.
Aims
Our aim was to survey Fellows of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) regarding bilateral salpingectomy compared to other procedures offered for permanent contraception at the time of caesarean section. Materials and Methods An online survey was utilised to collect clinician demographics, opinions, barriers, and justifications in regard to options of permanent surgical contraception at time of caesarean section.
Results
Bilateral salpingectomy was identified as the most effective method of permanent contraception at time of caesarean section. However, only 62% of respondents offer the procedure as a method of permanent contraception. The two most common reasons for clinicians to offer bilateral salpingectomy at time of caesarean section were evidence suggesting a link between the fallopian tube and gynaecological cancer (80%) and efficacy as a permanent form of contraception (16%). The primary barrier identified by 51% of respondents was perceived increased risk of surgical complications, followed by reasoning that it would not allow the possibility of future tubal reversal.
Conclusion
This study identifies diverse opinions on surgical approach to permanent contraception at time of caesarean section and offered by clinicians of RANZCOG. Further research is required to establish safety profiles and short‐ and long‐term risks of bilateral salpingectomy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Obstetrics and Gynaecology Department, Westmead Hospital, Sydney, New South Wales, Australia.
- Sydney West Advanced Pelvic Surgery Unit, Sydney, New South Wales, Australia.
- Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.
- Gynaecological Oncology Department, Prince of Wales Hospital, Sydney, New South Wales, Australia.
- University of Sydney, Sydney, New South Wales, Australia.
- Gynaecological Oncology Department, Westmead Hospital, Sydney, New South Wales, Australia.
ORCID-Profile: Nargis Noori
Zitieren
APA
Noori, N., Edwards, L., Anpalagan, A., Athavale, R., Burling, M., Herbst, U., Brand, A., & Kapurubandara, S. (2024). Bilateral salpingectomy as an option of permanent contraception at time of caesarean section: A survey of practice. Australian and New Zealand Journal of Obstetrics and Gynaecology. https://doi.org/10.1111/ajo.13748
Vancouver
Noori N, Edwards L, Anpalagan A, Athavale R, Burling M, Herbst U, et al. Bilateral salpingectomy as an option of permanent contraception at time of caesarean section: A survey of practice. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2024. doi:10.1111/ajo.13748
BibTeX
@article{Noori2024,
author = {Noori, Nargis and Edwards, Laura and Anpalagan, Apputhurai and Athavale, Ramanand and Burling, Michael and Herbst, Unine and Brand, Alison and Kapurubandara, Supuni},
title = {Bilateral salpingectomy as an option of permanent contraception at time of caesarean section: A survey of practice},
journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
year = {2024},
doi = {10.1111/ajo.13748}
}
EUVIMED